Investigator(s):
The Lundquist Institute
LOS ANGELES – Los Angeles Biomedical Research Institute (LA BioMed) announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges. Frans J. Walther, MD, PhD, an LA BioMed lead researcher, will continue to pursue an innovative global health research project, titled “Aerosol Delivery of Synthetic Lung Surfactant.”
LA BioMed Partnering with QT Medical to Identify Infants at Risk of Long QT Syndrome
LOS ANGELES – (Oct. 28, 2014) –Each year, some 2,000 babies are born in the U.S. with a genetic heart condition, known as long QT syndrome. If not diagnosed in time, babies with long QT syndrome can die from a sudden arrhythmia, or irregular heartbeat.
Event also Will Recognize Dr. John Michael Criley for His Leadership
LOS ANGELES – (September 24, 2014) – On Oct. 18 at its Advancing Innovation Gala, Los Angeles Biomedical Research Institute (LA BioMed) will recognize three champions of innovation who are leading companies built on research conducted at LA BioMed: Timothy Cooke, PhD., Keith Leonard and Yutaka Niihara, MD.
The Advancing Innovation Gala also will honor John Michael Criley, MD, an LA BioMed Legend and researcher, who pioneered the modern U.S. paramedic model of providing emergency care.
Researchers Identify Why Hospitals May Not “Get in the Ring” to Fight “Superbug”
PHILADELPHIA – (Oct. 8, 2014) – Numerous experts and policy makers have called for hospitals to screen patients for methicillin-resistant Staphylococcus aureus (MRSA) infections and isolate anyone testing positive to prevent the spread of these so-called “Superbugs” in healthcare settings. Several states have enacted laws requiring patients be screened for MRSA upon admission.
LA BioMed Researchers Surveyed Emergency Patients Tested for THC Levels
LOS ANGELES – (Oct. 1, 2014) – Surveying patients with traumatic brain injury, a group of Los Angeles Biomedical Research Institute (LA BioMed) researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.
Investigator(s):
The Lundquist Institute
Researchers Find Method for Replacing Missing Enzyme in the Brain.
LOS ANGELES – (Oct. 1, 2014) – MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain, leading to profound intellectual disability, dementia and death — often before reaching adulthood.
Patients benefit from minimally invasive procedures.
LOS ANGELES – (September 23, 2014) –
Laparoscopic cholecystectomy, a minimally invasive procedure to remove the gallbladder, is one of the most common abdominal surgeries in the U.S. Yet medical centers around the country vary in their approaches to the procedure with some moving patients quickly into surgery while others wait.
New Research Executive Brings Wealth of Experience to Institute
LOS ANGELES – (August 18, 2014) – Bringing a wealth of experience in research administration, Susan D. Rubin recently joined Los Angeles Biomedical Research Institute (LA BioMed) in a newly created role of chief operating officer and general counsel.
LOS ANGELES – (August 15, 2014) – Los Angeles Biomedical Research Institute (LA BioMed) recently named six new members to its Board of Directors, expanding the board’s expertise in the law, scientific research, engineering, development, public affairs and more.
David B. Duthu, Dr. David Heber, Joan Hood Jones, Anne-Merelie Murrell, Barnet Resnick and Dan Rosenfeld have joined the board of LA BioMed, one of the nation’s leading nonprofit independent research institutes.
Investigator(s):
Kamyar Kalantar-Zadeh, MD, PhD
Kamyar Kalantar-Zadeh, the world’s foremost expert on end-stage kidney disease, has followed his research to the controversial proposition that obesity might be a patient’s best friend in the hour of greatest need.
Recent findings by Kalantar-Zadeh and some of his colleagues have landed him square in the middle of an “obesity paradox,” which is the subject of sometimes heated debate among physicians, researchers and public health officials.